Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Alabama Oncology
Birmingham Alabama 35211

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

University of Alabama at Birmingham
Birmingham Alabama 35294

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Southern Cancer Center
Mobile Alabama 36608

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

UPDATED

Birmingham Alabama

A clinical trial seeking patients for a research study of INCB054828 in Subjects with Advanced Malignancies

UPDATED

Birmingham Alabama 35211

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Mobile Alabama 36604

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Birmingham Alabama 35294-0006

A clinical research study of LEE011, BYL719, fulvestrant and BKM120 for the treatment of Breast Cancer

Birmingham Alabama 35294

A clinical research study of Trastuzumab, pertuzumab and lapatinib for the treatment of Breast Neoplasms

Birmingham Alabama

A clinical trial seeking patients for a research study for the treatment of Breast Cancer, Non-Small Cell Lung Cancer or Pancreatic Cancer

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Ointment and 0.1% Uracil Ointment for patients with Palmar-Plantar Erythrodysesthesia or Breast Cancer

Birmingham Alabama 35294

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating Neratinib and Loperamide for the treatment of Early Stage HER2+ Breast Cancer

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-LIV1A to evaluate Breast Cancer

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Mobile Alabama 36608

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

Mobile Alabama 36688

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Mobile Alabama 36604

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Arizona

Arizona Center for Cancer Care
Glendale Arizona 85306

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Phoenix Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Research Alliance
Scottsdale Arizona 85251

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Tucson Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Center
Tucson Arizona 85724

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Yuma Regional Cancer Center
Yuma Arizona 85364

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

UPDATED

Glendale Arizona

A clinical research study for the treatment of Breast Cancer or HER2 Positive Breast Cancer

UPDATED

Glendale Arizona 85304

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Scottsdale Arizona

A clinical research study for the treatment of Breast Cancer or HER2 Positive Breast Cancer

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

UPDATED

Tucson Arizona 85724

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Yuma Arizona 85364

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of CC-486 and Fulvestrant to evaluate Breast Neoplasms

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study evaluating Eniluracil, 5-Fluorouracil, Leucovorin and Capecitabine for the treatment of Metastatic Breast Cancer

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study of Veliparib, Carboplatin, Paclitaxel and Placebo to evaluate Metastatic Breast Cancer

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Scottsdale Arizona

A clinical trial seeking patients for a research study for the treatment of Breast Cancer, Non-Small Cell Lung Cancer or Pancreatic Cancer

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using BMN 673 and Physician's-Choice for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Pembrolizumab for patients with Breast Cancer, Triple-Negative Breast Cancer

Scottsdale Arizona 85259

A Phase 1 clinical study for patients using CX-4945 oral formulation

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of ABBV-075

Sedona Arizona 86336

A clinical trial to evaluate treatments using BMN 673 and Physician's-Choice for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

Sedona Arizona 86336

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Tucson Arizona 85704

A clinical trial to evaluate treatments using Ipatasertib, Paclitaxel and Placebo for patients with Breast Cancer

Tucson Arizona 85704

A clinical trial to evaluate treatments using Radiofrequency Ablation for patients with Breast Cancer

Tucson Arizona 85704

A Phase 3 clinical study for patients with Breast Cancer

Tucson Arizona 85710

A Phase 3 clinical study for patients with Breast Cancer

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Mifepristone and Eribulin in combination for the treatment of Breast Cancer

Tucson Arizona 85719

Patients are needed to participate in a clinical research study of Pertuzumab and Trastuzumab to evaluate Metastatic Breast Cancer (MBC)